Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential-Reference-Cited by-同舟云学术

Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential

Published:2017-09 Issue:3 Volume:48 Page:346-354
ISSN:1073-2322
Container-title:Shock
language:en
Short-container-title:

Author:

Kunz Natalia,Xia Brent T.,Kalies Kai-Uwe,Klinger Matthias,Gemoll Timo,Habermann Jens K.,Whitacre Brynne E.,Seitz Aaron P.,Kalies Kathrin,Caldwell Charles C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine

Reference44 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3);Singer;JAMA,2016

2. International forum of acute care: assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations;Fleischmann;Am J Respir Crit Care Med,2016

3. Why have clinical trials in sepsis failed?;Marshall;Trends Mol Med,2014

4. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?;Opal;Crit Care Med,2014

5. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?;Boomer;Virulence,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Extracellular Nano-Vesicles Can Play a Role in Sepsis? An Evidence-Based Review of the Literature;International Journal of Nanomedicine;2023-10

2. Macrophage-targeted Nanomedicine for Sepsis: Diagnosis and Therapy;Current Pharmaceutical Design;2023-07

3. Macrophages-regulating nanomedicines for sepsis therapy;Chinese Chemical Letters;2023-03

4. THE ROLES OF EXTRACELLULAR VESICLES IN SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;Shock;2022-11-03

5. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis;Frontiers in Immunology;2020-08-04